Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Stage Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04562337
What this trial is testing

SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Shandong Cancer Hospital and Institute 67
Not applicableLooking for participantsNCT05552846
What this trial is testing

Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy

Who this might be right for
Small-cell Lung Cancer
Ruijin Hospital 104
Testing effectiveness (Phase 2)Study completedNCT00182689
What this trial is testing

Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
National Cancer Institute (NCI) 89
Large-scale testing (Phase 3)Study completedNCT00045162
What this trial is testing

S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 671
Testing effectiveness (Phase 2)Study completedNCT02580994
What this trial is testing

Pembrolizumab in Untreated Extensive SCLC

Who this might be right for
Small Cell Lung Cancer (SCLC)
European Organisation for Research and Treatment of Cancer - EORTC 125
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05703997
What this trial is testing

FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction

Who this might be right for
Small Cell Lung Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 20
Large-scale testing (Phase 3)Study completedNCT02635009
What this trial is testing

Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CarcinomaLimited Stage Small Cell Lung Carcinoma
NRG Oncology 418
Not applicableWithdrawnNCT01325753
What this trial is testing

Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body

Who this might be right for
Advanced Malignant MesotheliomaExtensive Stage Small Cell Lung CancerLung Metastases+4 more
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Ended earlyNCT00791154
What this trial is testing

QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer

Who this might be right for
Lung CancerSmall Cell Lung CancerSolid Tumors+1 more
NantCell, Inc. 213
Testing effectiveness (Phase 2)Study completedNCT00156286
What this trial is testing

Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC

Who this might be right for
Small Cell Lung Cancer
University of Michigan Rogel Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT07373964
What this trial is testing

A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)

Who this might be right for
Small Cell Lung Cancer
China Medical University, China 36
Large-scale testing (Phase 3)Looking for participantsNCT07625644
What this trial is testing

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

Who this might be right for
Small Cell Lung Cancer Extensive StageSmall-cell Lung CancerSmall Cell Carcinoma+5 more
SystImmune Inc. 550
Early research (Phase 1)Study completedNCT02815592
What this trial is testing

Trial of BMS-986012 in Combination With Platinum and Etoposide

Who this might be right for
Small Cell Lung Cancer
Bristol-Myers Squibb 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT07802821
What this trial is testing

A Study Comparing QLC5508 in Combination With QL2107 Versus Tislelizumab Plus Platinum-based Chemotherapy in Participants Wih Treatment-naïve Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 556
Not applicableStudy completedNCT01999881
What this trial is testing

Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients

Who this might be right for
Extensive Stage Small Cell Lung CancerHealthy, no Evidence of DiseaseLimited Stage Small Cell Lung Cancer+9 more
University of Wisconsin, Madison 21
Not applicableEnrolling By InvitationNCT07390565
What this trial is testing

YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer (SCLC)
LI FENG 308
Testing effectiveness (Phase 2)Looking for participantsNCT07564401
What this trial is testing

Evaluate DJI136, a DLL3-targeted CAR-T Therapy

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Novartis Pharmaceuticals 80
Testing effectiveness (Phase 2)Looking for participantsNCT06780137
What this trial is testing

Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Who this might be right for
Small Cell Lung Cancer
Merck Sharp & Dohme LLC 327
Testing effectiveness (Phase 2)Looking for participantsNCT06287775
What this trial is testing

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaStage IV Lung Cancer AJCC v8
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07022301
What this trial is testing

Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy

Who this might be right for
Small Cell Lung Cancer Extensive StageResistance to Immunotherapy
First Affiliated Hospital of Wannan Medical College 25
Next Page